-
Most Recent
Search Results
240 results for ANV
Nvidia Can Hit Home Runs, but Championships Need a Full Lineup
Since 2023, Nvidia has reached superstar status with its massive earnings beats, often, like Babe Ruth, knocking it out of the park. But the bigger…
How I Found a 600% Winner Before Wall Street Caught On
In today’s Market 360, I want to tell you how my system found this company before Wall Street did, what it actually does – and…
Google May Define Agentic AI… but These Stocks Will Make Investors Richer
Agentic systems are the “next generation” of AI technologies that can make decisions by themselves and adapt to changes. But the most interesting agentic AI…
This AI Stock Has Even Faster Growth Than NVIDIA
This week is all about Wednesday. That’s when the grand finale of earnings season will take place. Of course, that’s when NVIDIA Corporation (NVDA) will…
Nvidia Crushed Earnings – But Wall Street Shrugs
Disappointing news from the Middle East… quantum computing in the crosshairs… the answer to “buy and hold” today… how high will the bond vigilantes push…
3 More Small-Cap Stocks to Buy
When “everyone knows” the same thing, opportunities tend to emerge elsewhere — especially in smaller companies that Wall Street often ignores. Today, I want to…
Forget “Sell in May” – This Could Be the Summer of Small Caps
In today’s Market 360, I want to explain why I think “sell in May” is exactly the wrong call this year. Then, I’ll make the…
Wall Street Is Pricing AI’s Upside. Nobody Is Pricing This.
The AI boom is surging. But rising energy costs, layoffs, and backlash could trigger regulation and end the rally sooner than expected.
NVIDIA Made My Followers Millionaires. Now I’m Looking for the Next One.
Last week, we crossed the 5,000% mark with one of my Growth Investor recommendations. The stock? NVIDIA Corporation (NVDA). It was a big deal, so…
ANVS Stock: The Huge News Sending Annovis Bio Rocketing 200% Today
A dual Alzheimer’s-Parkinson’s clinical trial is showing highly optimistic results for Annovis, and ANVS stock is up huge because of it.
ANVS Stock: The Alzheimer’s Drug News That Has Annovis Bio Plunging Today
Shares of ANVS stock are plummeting on Thursday after Annovis Bio reported weak results from two clinical trials for its leading drug.
Why Is Annovis Bio (ANVS) Stock Up 12% Today?
Annovis Bio (ANVS) stock is getting a boost on Thursday following news that the company will proceed with its Alzheimer’s clinical trial.
Why Did Annovis Bio (ANVS) Stock Close Up 80% Today?
ANVS stock closed up more than 75% today after Annovis announced encouraging clinical trial results for its Parkinson’s drug, buntanetap.
Looking for the Next Nvidia Stock? Start Here
Nvidia changed real investors’ lives. Now the same system that found it is flagging 53 possible early winners.
The End of the Bull Market Is Nigh
Michael Burry’s crash warning … the one macro risk that actually matters … why the earnings data tells a different story… where Louis Navellier and…
Stop Guessing the Market. Use AI Trading Signals Instead
Forget forecasts. AI trading signals identify repeatable patterns that drive profits in any market environment.
Inflation’s Back – Will It Crash the Market?
April inflation comes in hot… why Louis Navellier doesn’t expect relief at the pump anytime soon… but he’s bullish on this corner of the market……
Warren Buffett Is Nervous. Louis Navellier Is Buying.
No progress on peace talks over the weekend… why Buffett doesn’t like today’s market… why Louis Navellier loves today’s market… but Luke Lango is telling…
Annovis Bio (ANVS) Stock Soars 6% on Positive FDA Update
Annovis Bio (ANVS) stock is soaring higher on Thursday following a positive update from the FDA for its buntanetap clinical trial.
The Bond Market Just Flashed Red
The 10-year yield sets a 52-week high… a wedge pattern suggests a big move is coming… which way will it break?… a quick 140% winner…
ANVS Stock Earnings: Annovis Bio Beats EPS for Q2 2024
ANVS stock results show that Annovis Bio beat analyst estimates for earnings per share the second quarter of 2024.
ANVS Stock Earnings: Annovis Bio Misses EPS for Q4 2023
ANVS stock results show that Annovis Bio missed analyst estimates for earnings per share the fourth quarter of 2023.
ANVS Stock Earnings: Annovis Bio Beats EPS for Q1 2024
ANVS stock results show that Annovis Bio beat analyst estimates for earnings per share the first quarter of 2024.
2 – 10 of 240 results
